SOST and osteoporosis: Evidence revealed that sclerostin was higher as the BMD lower in DM patients [12], and studies revealed that as renal function worsened, higher levels of sclerostin were present, which highlighted its role in the pathogenesis and high prevalence of osteoporosis in CKD patients [2,3,4,14,18].